Skip to main content
Rianlon Corporation logo

Rianlon Corporation — Investor Relations & Filings

Ticker · 300596 ISIN · CNE100002MQ2 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,713 across all filing types
Latest filing 2020-12-17 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 300596

About Rianlon Corporation

https://www.rianlon.com

Rianlon Corporation is a global provider of anti-aging additives and technical solutions for polymer materials. The company focuses on the research, development, and production of high-performance antioxidants and light stabilizers, including ultraviolet absorbers (UVA) and hindered amine light stabilizers (HALS). Its product portfolio is designed to enhance the durability and lifespan of materials used in diverse applications such as plastics, coatings, rubber, adhesives, and synthetic fibers. Rianlon offers customized U-pack solutions to address specific degradation challenges faced by manufacturers. With a commitment to innovation and a robust global supply chain, the company provides comprehensive technical support and reliable material protection to ensure the long-term performance of polymer-based products across various industrial sectors.

Recent filings

Filing Released Lang Actions
董事会关于发行股份及支付现金购买资产并募集配套资金的一般风险暨复牌的提示性公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement by Tianjin Lianlong New Material Co., Ltd. regarding a proposed transaction involving issuance of shares and cash payment to purchase assets, along with a fundraising plan. It discusses various risks related to the transaction, including approval risks, suspension or termination risks, audit and evaluation uncertainties, performance commitments, goodwill impairment, and integration risks. The document also mentions the resumption of trading of the company's securities. The content is focused on informing investors about the risks and status of a capital raising and asset acquisition transaction, rather than presenting financial statements or detailed financial results. It is not a full financial report, earnings release, or audit report. The document is an update on capital/financing activities and related risks, fitting the category of Capital/Financing Update (CAP). The document length is 2251 characters, which is relatively short but contains substantive information about the transaction and risks, not merely an announcement of a report publication or a regulatory filing. Therefore, the best classification is CAP with high confidence.
2020-12-17 Chinese
独立董事关于第三届董事会第十八次会议相关事项的事前认可意见
Board/Management Information Classification · 95% confidence The document is a formal opinion from independent directors regarding matters to be discussed at the company's 18th board meeting of the third session. It includes pre-approval opinions on a major asset acquisition transaction and the appointment of the 2020 audit firm. The document references relevant laws and regulations and confirms the compliance and benefits of the proposed transaction and audit appointment. It is not a full audit report, annual report, or financial statement but rather a governance-related document expressing independent directors' opinions on board matters. This fits best under Board/Management Information (MANG), which covers announcements related to board decisions and management matters. The document length is short and does not contain financial statements or detailed financial analysis, so it is not an Annual Report or Audit Report. Therefore, the classification is MANG with high confidence.
2020-12-17 Chinese
独立董事关于第三届董事会第十八次会议相关事项的独立意见
Regulatory Filings Classification · 95% confidence The document is an independent opinion statement from the independent directors of Tianjin Lianlong New Materials Co., Ltd. regarding the 18th meeting of the third board of directors. It discusses the legality, feasibility, and fairness of a proposed transaction involving issuance of shares and cash to acquire a controlling stake in another company, as well as opinions on the use of remaining IPO funds and appointment of the 2020 audit firm. The document references compliance with laws and regulations, board meeting procedures, and shareholder interests. It does not contain financial statements or detailed financial data but rather provides independent directors' opinions on corporate governance matters related to a major asset acquisition and related corporate actions. This type of document is typically classified as a Regulatory Filing (RNS) because it is a formal regulatory disclosure of independent directors' opinions on significant corporate transactions and governance issues, not a full report like an Annual Report or Interim Report, nor a proxy solicitation or voting result announcement. The document length is short (2610 characters), and it is not a report publication announcement or certification letter. Therefore, the best fit is Regulatory Filings (RNS).
2020-12-17 Chinese
锦州康泰润滑油添加剂股份有限公司关于所提供信息之真实性、准确性和完整性的承诺
M&A Activity Classification · 95% confidence The document is a formal statement of commitment regarding the truthfulness, accuracy, and completeness of information provided in relation to a planned transaction involving the purchase of equity and fundraising. It is a legal assurance document related to a merger or acquisition transaction. There are no financial statements, audit results, or report data present. The document is short (744 characters) and does not contain financial results or detailed report content. It is not an announcement of a report publication but a commitment letter related to a transaction. Therefore, the document fits best under the category of M&A Activity (TAR), which covers announcements and documents related to merger proposals or takeover bids.
2020-12-17 Chinese
董事会关于本次交易前12个月内购买、出售资产的说明
Regulatory Filings Classification · 95% confidence The document is a statement from the board of directors of Tianjin Lianlong New Materials Co., Ltd. regarding asset purchases and sales within the last 12 months in relation to a planned transaction involving the acquisition of a controlling stake in another company. It references regulatory rules about major asset restructuring and cumulative calculations of asset transactions. The document is short (556 characters) and serves as an explanatory note or announcement about the transaction and compliance with regulatory requirements, rather than a full financial report or detailed transaction filing. It does not contain financial statements or detailed financial data. Therefore, it is best classified as a Regulatory Filing (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2020-12-17 Chinese
董事会关于本次交易符合《创业板上市公司证券发行注册管理办法（试行）》和《创业板上市公司持续监管办法（试行）》相关规定的说明
Capital/Financing Update Classification · 95% confidence The document is a detailed explanation by the board of Tianjin Lianlong New Materials Co., Ltd. regarding a planned transaction involving the issuance of shares and cash to acquire a controlling stake in another company. It references compliance with specific regulatory rules related to securities issuance and continuous supervision on the Growth Enterprise Market (创业板). The content focuses on the transaction's regulatory compliance, pricing, industry classification, and relationship between the companies involved. There is no financial statement data or earnings information, nor is it a simple announcement of a report. The document is clearly about a capital raising and acquisition transaction, fitting the category of Capital/Financing Update (CAP).
2020-12-17 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.